Literature DB >> 8350886

Effect of dietary fish oil on renal function and rejection in cyclosporine-treated recipients of renal transplants.

J J van der Heide1, H J Bilo, J M Donker, J M Wilmink, A M Tegzess.   

Abstract

BACKGROUND: Dietary fish oil exerts effects on renal hemodynamics and the immune response that may benefit renal-transplant recipients treated with cyclosporine. To evaluate this possibility, we studied the effect of fish oil on renal function, blood pressure, and the incidence of acute rejection episodes in cyclosporine-treated recipients of renal transplants.
METHODS: In a randomized, double-blind trial, 33 recipients of first cadaveric kidney transplants who were treated with cyclosporine and prednisolone ingested 6 g of fish oil daily during the first postoperative year (the fish-oil group), whereas another 33 renal-graft recipients treated with cyclosporine and prednisolone ingested 6 g of coconut oil daily for three months after which time it was stopped (the control group).
RESULTS: One year after transplantation, the fish-oil group had higher median values than the controls for glomerular filtration rate (53 vs. 40 ml per minute per 1.73 m2, P = 0.038) and effective renal plasma flow (214 vs. 178 ml per minute per 1.73 m2, P = 0.023) and lower mean arterial pressure (103 vs. 118 mm Hg, P = 0.0011). The cyclosporine doses in the two groups were similar. The cumulative number of rejection episodes was 20 in the controls, as compared with 8 in the fish-oil group (P = 0.029). One-year graft survival also tended to be better in the fish-oil group, (97 vs. 84 percent, P = 0.097).
CONCLUSIONS: The daily administration of 6 g of fish oil during the first postoperative year has a beneficial effect on renal hemodynamics and blood pressure in renal-transplant recipients treated with cyclosporine. Although the fish-oil group had significantly fewer rejection episodes than the control group, graft survival at one year was not significantly better in the fish-oil group.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8350886     DOI: 10.1056/NEJM199309093291105

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  22 in total

Review 1.  Calcineurin inhibitors and post-transplant hyperlipidaemias.

Authors:  R Moore; D Hernandez; H Valantine
Journal:  Drug Saf       Date:  2001       Impact factor: 5.606

Review 2.  Immunobiology and immunopharmacology of organ allograft rejection.

Authors:  M Suthanthiran; T B Strom
Journal:  J Clin Immunol       Date:  1995-07       Impact factor: 8.317

3.  Dietary fish oil diminishes lymphocyte adhesion to macrophage and endothelial cell monolayers.

Authors:  P Sanderson; P C Calder
Journal:  Immunology       Date:  1998-05       Impact factor: 7.397

Review 4.  Post-transplant hyperlipidaemia.

Authors:  R M Jindal
Journal:  Postgrad Med J       Date:  1997-12       Impact factor: 2.401

Review 5.  n-3 polyunsaturated fatty acids and human cytokine synthesis.

Authors:  S Endres
Journal:  Lipids       Date:  1996-03       Impact factor: 1.880

6.  The association between marine n-3 polyunsaturated fatty acid levels and survival after renal transplantation.

Authors:  Ivar A Eide; Trond Jenssen; Anders Hartmann; Lien M Diep; Dag O Dahle; Anna V Reisæter; Kristian S Bjerve; Jeppe H Christensen; Erik B Schmidt; My Svensson
Journal:  Clin J Am Soc Nephrol       Date:  2015-06-10       Impact factor: 8.237

Review 7.  Hyperfiltration nephropathy as a cause of late graft loss in renal transplantation.

Authors:  C Modlin; D Goldfarb; A C Novick
Journal:  World J Urol       Date:  1996       Impact factor: 4.226

Review 8.  Post-transplant dyslipidemia: Mechanisms, diagnosis and management.

Authors:  Arnav Agarwal; G V Ramesh Prasad
Journal:  World J Transplant       Date:  2016-03-24

Review 9.  Fish oil for kidney transplant recipients.

Authors:  Andy K H Lim; Karen J Manley; Matthew A Roberts; Margaret B Fraenkel
Journal:  Cochrane Database Syst Rev       Date:  2016-08-18

Review 10.  Interactions between cyclosporin and lipid-lowering drugs: implications for organ transplant recipients.

Authors:  Anders Asberg
Journal:  Drugs       Date:  2003       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.